Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,707 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term outcome of L86 and L97 protocols for adult acute lymphoblastic leukemia.
Koharazawa H, Kanamori H, Sakai R, Hashimoto C, Takemura S, Hattori M, Taguchi J, Fujimaki K, Tomita N, Fujita H, Fujisawa S, Harano H, Ogawa K, Motomura S, Maruta A, Ishigatsubo Y. Koharazawa H, et al. Among authors: ogawa k. Leuk Lymphoma. 2008 Nov;49(11):2133-40. doi: 10.1080/10428190802464711. Leuk Lymphoma. 2008. PMID: 19021056 Clinical Trial.
Evaluation of soluble interleukin-2 receptor and serum lactate dehydrogenase in malignant lymphoma.
Tomita N, Taguri M, Hashimoto C, Takasaki H, Fujimaki K, Motomura S, Koharazawa H, Takemura S, Fujita H, Yamazaki E, Kawasaki R, Taguchi J, Sakai R, Fujisawa S, Hattori Y, Kanamori H, Yamamoto W, Harano H, Ogawa K, Ishigatsubo Y. Tomita N, et al. Among authors: ogawa k. Ann Hematol. 2015 Nov;94(11):1935-7. doi: 10.1007/s00277-015-2448-2. Epub 2015 Jul 25. Ann Hematol. 2015. PMID: 26208667 No abstract available.
Hyper-recovery of platelets after induction therapy is a predictor of relapse-free survival in acute myeloid leukemia.
Yamazaki E, Kanamori H, Itabashi M, Ogusa E, Numata A, Yamamoto W, Ito S, Tachibana T, Hagihara M, Matsumoto K, Koharazawa H, Taguchi J, Tomita N, Fujimaki K, Fujita H, Fujisawa S, Ogawa K, Ishigatsubo Y. Yamazaki E, et al. Among authors: ogawa k. Leuk Lymphoma. 2017 Jan;58(1):104-109. doi: 10.1080/10428194.2016.1190969. Epub 2016 Jun 7. Leuk Lymphoma. 2017. PMID: 27267543
Prognostic significance of programmed cell death-1-positive cells in follicular lymphoma patients may alter in the rituximab era.
Takahashi H, Tomita N, Sakata S, Tsuyama N, Hashimoto C, Ohshima R, Matsuura S, Ogawa K, Yamamoto W, Kameda Y, Enaka M, Inayama Y, Kasahara M, Takekawa Y, Onoda N, Motomura S, Ishigatsubo Y, Takeuchi K. Takahashi H, et al. Among authors: ogawa k. Eur J Haematol. 2013 Apr;90(4):286-90. doi: 10.1111/ejh.12075. Epub 2013 Mar 7. Eur J Haematol. 2013. PMID: 23331211 Clinical Trial.
5,707 results